JAMES COLAR: Open Payments
NPI 1639436975 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 28 payments from 11 companies in 2025. Trend: 2023 $31 · 2024 $1,864 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $270 |
| Stryker Corporation | 4 | $115 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| BridgeBio Pharma, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: CDS - MCT/CEM Monitoring, ARTIX MT, General - Therapies, OPSUMIT, LifeVest, FLOWTRIEVER CATHETER, S, Attruby, SHINGRIX.
Industry payments across MI — which companies pay providers there.
